NYSE · BCC

Boise Cascade Company

$80.72 +$2.88 (+3.70%) 1D Market open

Key Metrics

$2.74B
Market cap
24.83×
P/E · TTM
$6.37B
Revenue · TTM
$110.33M
Net income
EPS · TTM $2.89
Dividend yield 1.3%
Free cash flow $38.59M
Beta · 1Y 0.92
EBITDA · TTM $310.34M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 24
    The stock moved +8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 24
  • May 19
    From its Feb 6 high, the share price fell 28%.

    Peak close $91.03 on Feb 6; trough close $65.47 on May 19. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.74B
Enterprise value$2.85B
Shares outstanding35.2M
52-wk range$65.00 – $91.97
Avg volume · 20D349.8K
Net cash −$109.48M
Book value / share$52.75
IndustryWholesale-Lumber & Other Construction Materials
ExchangeNYSE
About Boise Cascade Company
IPO dateFeb 6, 2013
Employees7660

Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E24.83
P/S0.43
P/FCF70.98
EV/EBITDA9.18
EV/Sales0.45
Graham №$58.54

Profitability

Gross
Operating 2.4%
Net 1.7%
FCF 0.6%
ROE / ROIC 5.3% · 5.2%

Financial Health

Current ratio2.77
Quick ratio1.37
Debt / equity0.22
Debt / EBITDA 1.44
Net cash −$109.48M
Working capital$1.11B

Cash Flow · TTM

Operating CF $266.64M
Capex −$228.05M
Free cash flow $38.59M
Buybacks $194.74M
Dividends paid $34.51M
Shareholder yield 8.4%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$58.54 vs $78.22
Trades 1.3× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings